276 related articles for article (PubMed ID: 37056121)
1. A pancreatic player in dementia: pathological role for islet amyloid polypeptide accumulation in the brain.
Bortoletto AS; Parchem RJ
Neural Regen Res; 2023 Oct; 18(10):2141-2146. PubMed ID: 37056121
[TBL] [Abstract][Full Text] [Related]
2. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation induced by amyloid-forming pancreatic amylin: Rationale for a mechanistic hypothesis.
Leibold NS; Despa F
Biophys Chem; 2024 Jul; 310():107252. PubMed ID: 38663120
[TBL] [Abstract][Full Text] [Related]
4. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
Ly H; Despa F
Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
[TBL] [Abstract][Full Text] [Related]
5. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice.
Höppener JW; Oosterwijk C; van Hulst KL; Verbeek JS; Capel PJ; de Koning EJ; Clark A; Jansz HS; Lips CJ
J Cell Biochem; 1994; 55 Suppl():39-53. PubMed ID: 7929617
[TBL] [Abstract][Full Text] [Related]
6. Bloodborne Pancreatic Amylin, A Therapeutic Target for Alzheimer's Disease.
Despa F
Curr Alzheimer Res; 2023 Feb; ():. PubMed ID: 36803745
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus.
Yang Y; Wang Q; Li G; Guo W; Yang Z; Liu H; Deng X
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2617-2629. PubMed ID: 36596222
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer's disease: two triggers, one disease.
Ferreira S; Raimundo AF; Menezes R; Martins IC
Neural Regen Res; 2021 Jun; 16(6):1127-1130. PubMed ID: 33269760
[TBL] [Abstract][Full Text] [Related]
9. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
Jaikaran ET; Clark A
Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
[TBL] [Abstract][Full Text] [Related]
10. The human islet amyloid polypeptide in protein misfolding disorders: Mechanisms of aggregation and interaction with biomembranes.
Saghir AE; Farrugia G; Vassallo N
Chem Phys Lipids; 2021 Jan; 234():105010. PubMed ID: 33227292
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
12. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
Ludvik B
Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes.
Mahboob A; Senevirathne DKL; Paul P; Nabi F; Khan RH; Chaari A
Int J Biol Macromol; 2023 Jan; 225():318-350. PubMed ID: 36400215
[TBL] [Abstract][Full Text] [Related]
14. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
15. Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease.
Raimundo AF; Ferreira S; Martins IC; Menezes R
Front Mol Neurosci; 2020; 13():35. PubMed ID: 32265649
[TBL] [Abstract][Full Text] [Related]
16. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.
Cooper GJ; Day AJ; Willis AC; Roberts AN; Reid KB; Leighton B
Biochim Biophys Acta; 1989 Dec; 1014(3):247-58. PubMed ID: 2690958
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of feline diabetes mellitus.
Lutz TA; Rand JS
Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide: does it play a pathophysiological role in the development of diabetes?
Bennet WM; Smith DM; Bloom SR
Diabet Med; 1994 Nov; 11(9):825-9. PubMed ID: 7705017
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment.
Smith AA; Moore KBE; Ambs PM; Saraswati AP; Fortin JS
Adv Biol (Weinh); 2022 Oct; 6(10):e2101301. PubMed ID: 35931462
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes.
Wijesekara N; Ahrens R; Wu L; Ha K; Liu Y; Wheeler MB; Fraser PE
Diabetes Obes Metab; 2015 Oct; 17(10):1003-6. PubMed ID: 26095311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
